Efficacy and Safety of Docetaxel plus Ramucirumab for Patients with Pretreated Advanced or Recurrent Non-small Cell Lung Cancer: Focus on Older Patients.
Onoi K, Yamada T, Morimoto K, Kawachi H, Tsutsumi R, Takeda T, Okada A, Tamiya N, Chihara Y, Shiotsu S, Takemura Y, Yamada T, Hasegawa I, Katayama Y, Iwasaku M, Tokuda S, Takayama K.
Onoi K, et al. Among authors: takemura y.
Target Oncol. 2024 Mar 11. doi: 10.1007/s11523-024-01045-0. Online ahead of print.
Target Oncol. 2024.
PMID: 38467958